GFC-201

N/A

Report date: 2024/10/16 16:17:30

Base Information

Drug NameGFC-201
Drug Alias NameGFC201
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionDisintegrin and metalloproteinase domain-containing protein 28 inhibitors
TargetsDisintegrin and metalloproteinase domain-containing protein 28
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGeneFrontier Corp
China Registration ClassN/A

Develop Information

Active CompaniesGeneFrontier Corp
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A